Department of Neurosurgery

Grand Rounds and Departmental Events

Newsletters

Rise in the Rankings

Neurology and Neurosurgery at Mount Sinai were ranked sixteenth in the nation, rising from twenty-first last year, by U.S. News & World Report in their July 14, 2008 issue. U.S. analyzed data on 5453 medical centers to rank 16 specialties. The rankings were based on several criteria, including reputation, mortality index, and other factors such as nurse staffing.

Clinical Trials

  • New clinical trial at Mount Sinai Comprehensive Brain Tumor Center for newly diagnosed glioblastoma multiforme (GBM): Phase II Trial of EGFRvIII Vaccine in the Treatment of Newly Diagnosed Glioblastoma Multiforme (GBM)
  • Clinical trials of novel treatments against ischemic brain injury
    • CLEAR - IVH
      An FDA sponsored trial of intraventricular administration of t-PA in patients with intracerebral hemorrhage (ICH) with extension of blood into the ventricular system. Enrollment is limited to patients 18-75 years of age who present within 48 hours of the onset of ICH.
    • MISTIE: Minimally Invasive (Stereotactic) Surgery + rt-PA for ICH Extraction
      An NIH- sponsored phase II trial of stereotactic removal of blood clot in patients who have suffered an intracerebral hemorrhage.
    • PRAISE: Preventing Recurrent Stroke in Minority Populations
      An NIH - sponsored trial of peer-led support groups in improving use of proven therapies to prevent recurrent stroke. Subject must be at least 40 years of age and have suffered a stroke or TIA withing the past 5 years and be able to interact in a group setting. This trial will begin recruiting in the second half of 2008.
    • WARCEF: Warfarin Aspirin for Reduced Cardiac Ejection Fraction
      This study is addressing the question of whether warfarin or aspirin is better for the prevention of stroke in patients with a reduced cardiac ejection fraction (reduced cardiac output). Patients with a recent TIA or stroke and impaired cardiac contractility are eligible.

Neuro-Oncology Tumor Board Meetings

The Neuro-Oncology Tumor Board, a multidisciplinary team including Neurosurgery, Neurology, Neuropathology, Neuroradiology, Neoplastics, and Rehabilitation Medicine, meets Thursdays from 9:00 A.M. - 10:00 A.M. in the Radiology Conference Room, MC level, room AMC 331. Submit cases for discussion to Lannie Ramirez-Williams, Research Coordinator: lannie.ramirez-williams@mountsinai.org. Please include DOB, MRN, and brief medical synopsis.

Save the Date

Brain AVMs: Endovascular Nidal Occulsion and Paradigm Shift in Multi-modality Treatment"
Sidney A. Hollin, MD, Endowed Lecture
Presenter: Aman Patel, M.D.
Associate Professor of Neurosurgery and Radiology
Date: Wednesday, October 22, 2008
Time: 8:00 AM
Location: Mount Sinai School of Medicine, Annenberg 5 Board Room

Previous Courses

Documents above marked pdf are viewable with the free AdobeTM AcrobatTM Reader. If you do not have Acrobat Reader, click on the image below to download it.

Get Adobe Acrobat Reader